GLP-1

Latest news and articles about GLP-1 from NEX English

Launch High-Dose Wegovy at Competitive Prices in Obesity Drug Market

Novo Nordisk has announced the launch of a new high-dose GLP-1 injection for obesity treatment, priced $50 lower than its competitor Zepbound. This release comes amid increasing competition in the obesity medication market.

Novo Nordisk Discusses Competition in Expanding Weight Loss Drug Market

Novo Nordisk has announced new details regarding competition in the weight loss drug market following Eli Lilly's recent approval of a new obesity treatment. This comes as the obesity drug market experiences significant expansion with the introduction of new subscription models.